Screen play: the suddenly hot market for high-risk HPV tests, where Roche diagnostics is launching against two entrenched brands, offers a window into a future of personalized medicine and the convergence of drugs, diagnostics and devices. Matthew Arnold reports

Authors :: Arnold, Matthew
Source :: Medical Marketing & Media. June, 2011, Vol. 46 Issue 6, p32, 5 p.
Publication Year :: 2011
Abstract: In April, FDA approved Roche Diagnostics' Cobas HPV test (below), which uses Polymerase Chain Reaction technology to screen for 14 high-risk HPV types, including types 16 and 18, which are [...]

Subjects :: Roche Diagnostics Corp. -- Product development -- Licensing, certification and accreditation
Medical test kit industry -- Product development -- Licensing, certification and accreditation
Medical equipment and supplies industry -- Product development -- Licensing, certification and accreditation
Diagnostic equipment (Medical) -- Licensing, certification and accreditation -- Product development
Business
Health care industry
Cobas HPV (Diagnostic agent) -- Licensing, certification and accreditation

Tools